Ayuda
Ir al contenido

Dialnet


Resumen de Spinal cord compression of neoplastic origin: surgical experience using a common clinical language

Oscar Godino, Ignacio Visus, Iago Garreta, Luis López Obarrio, Lluis González Cañas, Juan José Sánchez Fernández, María del Mar Marin Melia, Abelardo Montero Sáez, Héctor Pérez Montero, Leyre Asiaín, Arturo Navarro Martín

  • Purpose To assess the value of a common clinical language in a multidisciplinary tumour board for spinal metastasis, using both the Rades score and the Spinal Instability Neoplastic Score (SINS) for multidisciplinary decision-making.

    Methods Retrospective study of 60 consecutive patients treated surgically for MSCC. The indication for surgery was done in a multidisciplinary board, basically according to SINS and RADES scores. Three prognostic groups were defined according to the Rades score: poor (Rades 1: 20–30 points), intermediate (Rades 2: 31–35), and good (Rades 3: 36–45).

    Results The 2-year overall survival (OS) rate was 50%, with median survival of 19 months. By Rades prognostic group (1, 2, 3), median OS was 6 months, 15 months, and not reached, respectively. OS rates at 6 months (Rades 1, 2, 3) were 51, 69, and 74.1%, respectively. Within the Rades 1 group, 6-month survival in patients with new-onset cancer was 68 vs. 40% in those with a known primary. The overall complication rate ≥ grade 3 was 23.3% (n = 14). In patients who underwent urgent surgery (< 48 h), the complication rate was 45.5% (5/11) versus 18.3% (9/49) in the planned surgeries.

    Conclusions Our findings supports the utility of using a common language in multidisciplinary tumour board for spinal metastasis. The 2-year OS rate in this series was 50%, which is the highest OS reported to date in this population. In the poor prognosis subgroup (Rades 1), OS at 6 months was higher in patients with new-onset cancer versus those with a known primary (68 vs. 40%). These findings suggest that surgery should be the first treatment option in patients with MSCC as first symptom of cancer although a predicted poor prognosis.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus